Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Type of Pluripotent Cell Discovered In Adult Breast Tissue

Published: Tuesday, March 05, 2013
Last Updated: Tuesday, March 05, 2013
Bookmark and Share
Human body carries personalized “patch kit," Say UCSF scientists.

UC San Francisco researchers have found that certain rare cells extracted from adult breast tissue can be instructed to become different types of cells – a discovery that could have important potential for regenerative medicine.

As with human embryonic stem cells, the newly found cells are pluripotent, or capable of turning into most cell types, the authors said. The scientists discovered that when the cells were put either in mice, or in cell culture, the cells could differentiate to produce multiple cell types, including those that proceed to make heart, intestine, brain, pancreas and even cartilage.
The finding is significant, the authors said, because scientists previously believed that pluripotent cells did not exist in the body after the embryonic stage of human development.

While a therapeutic use of the cells has yet to be determined, they could potentially generate new tissue – a “patch kit" – to heal wounds or reconstruct damaged or missing organs. They also could be used as a resource to study how cells become pluripotent, and how they repair and replace themselves.

“The ability of cells from an adult body to make so many tissue derivatives was completely unexpected,” said senior author Thea D. Tlsty, PhD, a UCSF professor of pathology. “When we saw that they could make cartilage, bone, gut, brain, pancreas cells – and even beating heart tissue – we were excited and intrigued.”

The study was published on Monday, March 4, in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS).

UCSF has pioneered research on regenerative medicine in a broad array of animal and human cell studies. Last year, Shinya Yamanaka, MD, PhD, a senior investigator at the UCSF-affiliated Gladstone Institutes and a UCSF professor of anatomy, won the Nobel Prize in Medicine for his discovery of a way to reprogram ordinary human skin cells into stem cells that can be used to better understand and treat a number of human diseases. Other projects at UCSF include work by Allan Basbaum, PhD, to modify stem cells to treat pain and rebuild damaged nervous systems.

Unique Characteristics of Newly Discovered Cells

Though the newly discovered cells share some characteristics of embryonic stem cells, they appear to be unique to themselves, said Tlsty. They are mortal and genetically stable – characteristics that are barriers to subsequent cancer formation, which is a factor that could prove valuable if the cells are to be used for regenerative medicine, she explained. By contrast, human embryonic stem cells as well as engineered induced pluripotent stem cells, also known as iPS cells, are immortal and genetically unstable.

Additionally, the cells can expand to an extensive yet finite number before they stop growing. One cell can grow for almost 60 population doublings, producing in excess of one billion daughter cells, conceptually providing enough cells to help in the recovery of damaged or diseased tissue.
The scientists are currently searching for the rare cells in other organs of the body. They hypothesize that these “universal patch kits” are scattered throughout the body of adult men and women.

The special cells were discovered and isolated in healthy breast tissue from women of various ages and ethnicities who were undergoing breast reductions. All tissues used in the study were devoid of visible disease or contamination, the authors say.

The breast tissue in the study was separated into single cells, and specific markers were used to pull out the rare population of cells.

From Breast Tissue to Beating Heart Cells

Even a single one of these endogenous pluripotent somatic (ePS) cells, when placed in the appropriate conditions, exhibited the same pluripotent power to self-renew and to generate multiple lineages – both in vitro and in vivo – as embryonic stem cells. The cells could develop into any of the three germ layers: endoderm (such as the pancreas and gastrointestinal tract), the mesoderm (bone, heart muscle, blood vessel), or ectoderm (breast tissues and nervous system).

For example, when properly instructed, some ePS cells made human breast tissue that produced milk in transplanted mice, while other cells generated cartilage structures. To the surprise of the researchers, when the cells were differentiated into heart muscle, they even demonstrated the spontaneous beating seen in cardiomyocytes, or “beating heart” cells.

“The cells we describe here exist in the body devoid of commitment,” the authors wrote. “Taken together, these studies provide morphological, molecular and functional evidence of lineage plasticity of these cells. They will make human milk, bone, fat – they will beat like a heart.”

Only a small fraction of certain mammary cells have “this complete and sustained” unique profile capable of morphing themselves, the researchers said.

“Future research will tell us if we lose access to these cells as we age, if they are found in all tissues, and if they can be used to rescue diseased tissues,” said Tlsty.

“The observation that rare cells within an adult human body have the capacity to differentiate into many tissue types under different physiological cues will facilitate a fascinating area of research into the physiology and therapeutic potential of these cells,” said lead author Somdutta Roy, PhD, a postdoctoral fellow at the UCSF Department of Pathology and the UCSF Helen Diller Family Comprehensive Cancer Center.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Saturday, June 25, 2016
Rates of Nonmedical Prescription Opioid Use Disorder Double in 10 Years
Researchers at NIH have found that the nonmedical use of prescription opioids has more than doubled among adults in the United States from 2001-2002 to 2012-2013.
Thursday, June 23, 2016
Peanut Allergy Prevention Strategy is Nutritionally Safe
Early-life peanut consumption does not affect duration of breastfeeding or children’s growth and nutrition.
Wednesday, June 22, 2016
NIH Launches Large Study of Pregnant Women in Areas Affected by Zika virus
Researchers at NIH and Fiocruz have begun a study to evaluate the magnitude of health risks that Zika virus infection poses to pregnant women and their developing fetuses and infants.
Wednesday, June 22, 2016
New Imaging Method May Predict Risk of Post-Treatment Brain Bleeding After Stroke
Researchers at NIH have developed technique that provides new insight into stroke.
Tuesday, June 21, 2016
Study Reveals Central Role of Endocannabinoids in Habit Formation
The new study findings point to a previously unknown mechanism in the brain that regulates the transition between goal-directed and habitual behaviors.
Tuesday, June 21, 2016
Predicting Effective Drug Combinations For TB
Researchers analyzed gene regulatory networks to explain the effectiveness of an experimental drug combination against drug-resistant tuberculosis bacteria.
Wednesday, June 15, 2016
Genomic Data Commons Launched
Part of the National Cancer Moonshot, the GDC will centralize and standardize accessible data.
Tuesday, June 07, 2016
Prevention May be Essential to Reducing Racial Disparities in Stroke
Researchers at NIH have found study provides clues to differences in stroke deaths between blacks and whites.
Friday, June 03, 2016
NIH Funds Biobank To Support Precision Medicine Initiative Cohort Program
$142 million over five years will be awarded to the Mayo Clinic to establish the world’s largest research-cohort biobank for the PMI Cohort Program
Friday, May 27, 2016
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Friday, May 27, 2016
New NIH-EPA Research Centers to Study Environmental Health Disparities
Scientists will partner with community organizations to study these concerns and develop culturally appropriate ways to reduce exposure to harmful environmental conditions.
Thursday, May 26, 2016
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
Wednesday, May 25, 2016
Visual Impairment, Blindness Cases in U.S. Expected to Double by 2050
Researchers at NIH have suggested that there is a need for increased screening and interventions to identify and address treatable causes of vision loss.
Friday, May 20, 2016
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Wednesday, May 18, 2016
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Dengue Virus Exposure May Amplify Zika Infection
Researchers at Imperial College London have found that the previous exposure to the dengue virus may increase the potency of Zika infection.
Gender Determination in Forensic Investigations
This study investigated the effectiveness of lip print analysis as a tool in gender determination.
Identifying Novel Types of Forensic Markers in Degraded DNA
Scientists have tried to verify the nucleosome protection hypothesis by discovering STRs within nucleosome core regions, using whole genome sequencing.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!